Complex Generic Approval Delays Getting Congressional Attention

 
• By Derrick Gingery

US Energy and Commerce Committee leaders request data on complex generic approvals, guidances, saying additional changes may be needed for faster approvals.

Capitol Building, Washington DC
A bipartisan group of House Energy and Commerce Committee members want information from FDA on complex generic approvals, potentially to consider ways of streamlining the process.

More from Generics

More from Biosimilars & Generics